Physician profile
Zoe Baker
NPI 1053191908
$1,930.44
in general payments reported to CMS, 2019-2025
11 companies · $934 in 2025
The $934 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $135 · 2024: $861 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.85 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $429.94 | 2024-2025 | |
| Alcon Vision LLC | $365.29 | 2023-2025 | Wavelight Refractive Suite, Clareon, Precision 1 |
| Tarsus Pharmaceuticals, INC. | $326.93 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $223.71 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Abbvie INC. | $131.68 | 2024-2025 | |
| Rxsight INC | $131.06 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Lensar, INC. | $116.15 | 2025 | Lensar Laser System |
| Carl Zeiss Meditec USA, INC. | $110.15 | 2023 | Artevo 800 |
| Harrow Eye, LLC | $48.79 | 2025 | Vevye, Iheezo |
| Oyster Point Pharma, INC. | $32.85 | 2024 | Tyrvaya |
| Biotissue Holdings INC. | $13.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zoe Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.